All In Biotech

Drug Trial Radar · NCT05916339

AWARE: Management of ADHD in Autism Spectrum Disorder

Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 1, 2023

Primary completion

Jan 1, 2027

Study completion Dec 30, 2027

Sponsor

Lead sponsor
Daniel CouryAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Patient-Centered Outcomes Research Institute; University of California, Irvine; Holland Bloorview Kids Rehabilitation Hospital; University of Rochester; Nationwide Children's Hospital; Children's Hospital Medical Center, Cincinnati; University of Virginia; University of Alberta; Massachusetts General Hospital; MaineHealth; University of Michigan; University of Pittsburgh; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Prisma Health-Upstate
First posted
Jun 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Health services research
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.

Conditions

  • ADHD
  • Autism Spectrum Disorder

Interventions

  • Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medicationDrug

    Amphetamine (AMP) medication names: Adderall, Adderall XR, Adzenys ER, Adzenys XR-ODT, Dayanavel XR, Dexedrine (spansule), Dexedrine (tablet), Mydayis, Procentra liquid Methylphenidate (MPH) medication names: Adhansia XR, Aptensio XR, Azstarys, Concerta, Cotempla XR-ODT, Daytrana, Focalin, Focalin XR, Jornay PM. Metadate CD, Methylin (liquid), Ritalin, Ritalin LA, Quillichew ER, Quillivant XR (liquid)

  • Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.Drug

    If first line stimulant therapy (Amphetamine/Methylphenidate) is deemed not effective or tolerable, re-randomization to the alternate stimulant or alpha-2 agonist will occur. If participant is satisfied with first line stimulant treatment, first-line stimulant therapy will continue. Catapres, Clonidine, Guanfacine, Intuniv, Kapvay, Tenex

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Vanderbilt Parent Rating ScaleTime frame: 16 Weeks

Locations

13 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, Irvine

    Irvine, California · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Maine Medical Center

    Portland, Maine · Recruiting

  • Massachusetts General Hospital Lurie Center for Autism

    Boston, Massachusetts · Recruiting

  • University of Rochester

    Rochester, New York · Recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • Nationwide Children's Hospital

    Columbus, Ohio · Recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • University of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • Prisma Health Upstate

    Greenville, South Carolina · Recruiting

  • University of Virginia

    Charlottesville, Virginia · Recruiting

  • University of Alberta, Glenrose Rehabilitation Hospital

    Edmonton, Canada · Recruiting

  • Holland Bloorview Kids Rehabilitation Hospital

    Toronto, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.